World

World

Don’t use Gilead’s remdesivir in hospitalised COVID-19 patients, WHO says

By Kate Kelland LONDON (Reuters) – Gilead’s remdesivir should not be used for patients hospitalised with COVID–19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday. “The … panel found a lack of evidence that remdesivir improved outcomes that matter to patients,” the guideline said. “Especially given […]